Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors

V. Corbière, H. Nicolay, V. Russo, V. Stroobant, V. Brichard, T. Boon, P. Van Der Bruggen

Research output: Contribution to journalArticle

Abstract

'Cancer germline' genes such as those of the MAGE family are expressed in many tumors and in male germline cells but are silent in normal tissues. They encode shared tumor-specific antigens that have been used in therapeutic vaccination trials of cancer patients. We report the identification of a new MAGE-1-encoded peptide that is recognized by a cytolytic T-lympnocyte (CTL) clone on human leukocyte antigen (HLA)-B*5701. The sequence of the peptide, corresponding to position 102-112 of the MAGE-1 protein sequence, is ITKKVADLVGF. When tumor cells expressing MAGE-1 were transfected with HLA-B*5701, they were lyzed by the CTL clone, indicating that the peptide is processed in tumor cells and can, therefore, be used as a target for anti-tumoral vaccination.

Original languageEnglish
Pages (from-to)453-457
Number of pages5
JournalTissue Antigens
Volume63
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

T-cells
HLA Antigens
Tumors
T-Lymphocytes
Peptides
Neoplasms
Vaccination
Clone Cells
Cells
Neoplasm Genes
Neoplasm Antigens
Genes
Tissue
Antigens
Proteins
Therapeutics

Keywords

  • Antigen
  • Cytolytic T lymphocyte
  • Dendritic cells
  • HLA-B57
  • MAGE
  • Peptide
  • Poxvirus
  • Tumor

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Corbière, V., Nicolay, H., Russo, V., Stroobant, V., Brichard, V., Boon, T., & Van Der Bruggen, P. (2004). Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors. Tissue Antigens, 63(5), 453-457. https://doi.org/10.1111/j.0001-2815.2004.00203.x

Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors. / Corbière, V.; Nicolay, H.; Russo, V.; Stroobant, V.; Brichard, V.; Boon, T.; Van Der Bruggen, P.

In: Tissue Antigens, Vol. 63, No. 5, 05.2004, p. 453-457.

Research output: Contribution to journalArticle

Corbière, V, Nicolay, H, Russo, V, Stroobant, V, Brichard, V, Boon, T & Van Der Bruggen, P 2004, 'Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors', Tissue Antigens, vol. 63, no. 5, pp. 453-457. https://doi.org/10.1111/j.0001-2815.2004.00203.x
Corbière, V. ; Nicolay, H. ; Russo, V. ; Stroobant, V. ; Brichard, V. ; Boon, T. ; Van Der Bruggen, P. / Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors. In: Tissue Antigens. 2004 ; Vol. 63, No. 5. pp. 453-457.
@article{a44d9ce4cefa4ced8a84688ec1a184aa,
title = "Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors",
abstract = "'Cancer germline' genes such as those of the MAGE family are expressed in many tumors and in male germline cells but are silent in normal tissues. They encode shared tumor-specific antigens that have been used in therapeutic vaccination trials of cancer patients. We report the identification of a new MAGE-1-encoded peptide that is recognized by a cytolytic T-lympnocyte (CTL) clone on human leukocyte antigen (HLA)-B*5701. The sequence of the peptide, corresponding to position 102-112 of the MAGE-1 protein sequence, is ITKKVADLVGF. When tumor cells expressing MAGE-1 were transfected with HLA-B*5701, they were lyzed by the CTL clone, indicating that the peptide is processed in tumor cells and can, therefore, be used as a target for anti-tumoral vaccination.",
keywords = "Antigen, Cytolytic T lymphocyte, Dendritic cells, HLA-B57, MAGE, Peptide, Poxvirus, Tumor",
author = "V. Corbi{\`e}re and H. Nicolay and V. Russo and V. Stroobant and V. Brichard and T. Boon and {Van Der Bruggen}, P.",
year = "2004",
month = "5",
doi = "10.1111/j.0001-2815.2004.00203.x",
language = "English",
volume = "63",
pages = "453--457",
journal = "Tissue Antigens",
issn = "0001-2815",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors

AU - Corbière, V.

AU - Nicolay, H.

AU - Russo, V.

AU - Stroobant, V.

AU - Brichard, V.

AU - Boon, T.

AU - Van Der Bruggen, P.

PY - 2004/5

Y1 - 2004/5

N2 - 'Cancer germline' genes such as those of the MAGE family are expressed in many tumors and in male germline cells but are silent in normal tissues. They encode shared tumor-specific antigens that have been used in therapeutic vaccination trials of cancer patients. We report the identification of a new MAGE-1-encoded peptide that is recognized by a cytolytic T-lympnocyte (CTL) clone on human leukocyte antigen (HLA)-B*5701. The sequence of the peptide, corresponding to position 102-112 of the MAGE-1 protein sequence, is ITKKVADLVGF. When tumor cells expressing MAGE-1 were transfected with HLA-B*5701, they were lyzed by the CTL clone, indicating that the peptide is processed in tumor cells and can, therefore, be used as a target for anti-tumoral vaccination.

AB - 'Cancer germline' genes such as those of the MAGE family are expressed in many tumors and in male germline cells but are silent in normal tissues. They encode shared tumor-specific antigens that have been used in therapeutic vaccination trials of cancer patients. We report the identification of a new MAGE-1-encoded peptide that is recognized by a cytolytic T-lympnocyte (CTL) clone on human leukocyte antigen (HLA)-B*5701. The sequence of the peptide, corresponding to position 102-112 of the MAGE-1 protein sequence, is ITKKVADLVGF. When tumor cells expressing MAGE-1 were transfected with HLA-B*5701, they were lyzed by the CTL clone, indicating that the peptide is processed in tumor cells and can, therefore, be used as a target for anti-tumoral vaccination.

KW - Antigen

KW - Cytolytic T lymphocyte

KW - Dendritic cells

KW - HLA-B57

KW - MAGE

KW - Peptide

KW - Poxvirus

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=2442547305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442547305&partnerID=8YFLogxK

U2 - 10.1111/j.0001-2815.2004.00203.x

DO - 10.1111/j.0001-2815.2004.00203.x

M3 - Article

C2 - 15104676

AN - SCOPUS:2442547305

VL - 63

SP - 453

EP - 457

JO - Tissue Antigens

JF - Tissue Antigens

SN - 0001-2815

IS - 5

ER -